FETZIMA

Abbvie Corporation🇨🇦 Health Canada

Approval Id: 162acd1efaed1f15
Drug Approval Canada Name: FETZIMA
Product Name: FETZIMA
Status: Marketed
Status Date: 2023-10-10
Original Market Date: 2016-04-22
Din: 02440997
Drug Class: Human
Dosage Form: Capsule (Extended Release)
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:16.04.92
Atc Original: N06AX28 LEVOMILNACIPRAN
Atc Name: n 06 ax 28
Aig Number: 0156890003
Company Name: Abbvie Corporation
Company Address: 8401 Trans-Canada Highway, Saint-Laurent, Quebec, Canada, H4S 1Z1
Company Detail Path: /organization/abbvie-corporation

LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE)

80 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

162acd1efaed1f15

Type

Standard